Paraneoplastic Morvan's syndrome following surgical treatment of recurrent thymoma: A case report

Galié,Edvina; Renna,Rosaria; Plantone,Domenico; Pace,Andrea; Marino,Mirella; Jandolo,Bruno; Koudriavtseva,Tatiana

doi:10.3892/ol.2016.4922

Paraneoplastic Morvan's syndrome following surgical treatment of recurrent thymoma: A case report

Authors:
- Edvina Galié
- Rosaria Renna
- Domenico Plantone
- Andrea Pace
- Mirella Marino
- Bruno Jandolo
- Tatiana Koudriavtseva
View Affiliations

Affiliations: Unit of Neurology, Regina Elena National Cancer Institute, Istituti Fisioterapici Ospitalieri, I‑00144 Rome, Italy, Institute of Neurology, Catholic University of Sacred Heart, I‑00168 Rome, Italy, Department of Pathology, Regina Elena National Cancer Institute, Istituti Fisioterapici Ospitalieri, I‑00144 Rome, Italy
Published online on: July 29, 2016 https://doi.org/10.3892/ol.2016.4922
Pages: 2716-2719

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Morvan's syndrome (MoS) is a rare, complex neurological disorder characterized by neuromyotonia, neuropsychiatric features, dysautonomia and neuropathic pain. The majority of MoS cases have a paraneoplastic aetiology, usually occurring prior to the diagnosis of the underlying tumour and showing improvement following its treatment. The present study reports the case of a 35‑year‑old Caucasian male patient who was diagnosed with stage IVA thymoma. Thymectomy, lung resection, diaphragmatic pleurectomy and pericardio‑phrenectomy were performed 6 months after neoadjuvant chemotherapy. The pathological evaluation revealed a type B2‑B3 thymoma with focal squamous differentiation. Two years later, the patient underwent new surgical treatment for a local recurrence of the same histological type, and 4 weeks later, the patient presented with complex neurological symptoms compatible with MoS, including neuromyotonia, neuropsychiatric features, dysautonomia and neuropathic pain. Electromyography was compatible with a diagnosis of neuromyotonia. Brain magnetic resonance imaging scan and tests for serum anti‑acetylcholine receptor, anti‑striated muscle antibodies and anti‑30‑kDa titin fragment antibodies were all negative, whereas tests for anti-voltage-gated potassium channel (VGKC)‑complex antibodies (333.3 pmol/l), anti‑leucine‑rich glioma inactivated protein 1 and anti-contactin-associated protein‑like 2 antibodies were positive. The patient underwent 3 cycles of intravenous administration of immunoglobulins (0.4 g/kg/day for 5 days every 4 weeks) with little clinical and electrophysiological improvement. We speculated that the late onset of the symptoms in the present patient may have been triggered by an increase in the serum level of anti‑VGKC antibody, which was caused by the surgery performed for the treatment of recurrent thymoma. To the best of our knowledge, the present report is the first case of MoS associated with this histological type of thymoma uncommonly occurring upon surgical treatment of recurrent thymoma.

View Figures

View References

1	Irani SR, Pettingill P, Kleopa KA, Schiza N, Waters P, Mazia C, Zuliani L, Watanabe O, Lang B, Buckley C and Vincent A: Morvan syndrome: Clinical and serological observations in 29 cases. Ann Neurol. 72:241–255. 2012. View Article : Google Scholar : PubMed/NCBI
2	Morvan A: De la chorèe fibrillaire. Gazzette Hebdomadaire de Mèdecine et de Chirurgie. 27:173–200. 1890.
3	Robain O and Attal C: Morvan's analgesic panaris in a 7-year-old child. Arch Fr Pediatr. 31:405–410. 1974.(In French). PubMed/NCBI
4	Murri L, Bonuccelli U, Iudice A and Simonetti C: Sleep disturbances in a case of Morvan's chorea (author's transl). Riv Patol Nerv Ment. 97:350–356. 1976.(In Italian). PubMed/NCBI
5	Lee EK, Maselli RA, Ellis WG and Agius MA: Morvan's fibrillary chorea: A paraneoplastic manifestation of thymoma. J Neurol Neurosurg Psychiatry. 65:857–862. 1998. View Article : Google Scholar : PubMed/NCBI
6	Jaben EA and Winters JL: Plasma exchange as a therapeutic option in patients with neurologic symptoms due to antibodies to voltage-gated potassium channels: A report of five cases and review of the literature. J Clin Apher. 27:267–273. 2012. View Article : Google Scholar : PubMed/NCBI
7	Otani S, Kawamura M, Sasaki H, Nakazawa S, Ohara H, Shimada T, Kamitani T, Asato Y, Suzuki M and Sekizuka E: Case report; A case of Morvan syndrome: a paraneoplastic manifestation of angioimmunoblastic T-cell lymphoma. Nihon Naika Gakkai Zasshi. 101:3519–3521. 2012.(In Japanese). View Article : Google Scholar : PubMed/NCBI
8	Loukaides P, Schiza N, Pettingill P, Palazis L, Vounou E, Vincent A and Kleopa KA: Morvan's syndrome associated with antibodies to multiple components of the voltage-gated potassium channel complex. J Neurol Sci. 312:52–56. 2012. View Article : Google Scholar : PubMed/NCBI
9	Abou-Zeid E, Boursoulian LJ, Metzer WS and Gundogdu B: Morvan syndrome: A case report and review of the literature. J Clin Neuromuscul Dis. 13:214–227. 2012. View Article : Google Scholar : PubMed/NCBI
10	Ong E, Viaccoz A, Ducray F, Pérol M, Cavillon G, Rogemond V, Honnorat J and Petiot P: Dramatic improvement after rituximab in a patient with paraneoplastic treatment-refractory Morvan syndrome associated with anti-CASPR2 antibodies. Eur J Neurol. 20:e96–e97. 2013. View Article : Google Scholar : PubMed/NCBI
11	Lukas RV, Rezania K, Malec M and Salgia R: Teaching Video NeuroImages: Myokymia and nerve hyperexcitability as components of Morvan syndrome due to malignant thymoma. Neurology. 80:e552013. View Article : Google Scholar : PubMed/NCBI
12	Sharma S and Sharma P: Morvan syndrome: After scrotal sac drainage and chemical instillation in hydrocele. Neurol India. 61:300–302. 2013. View Article : Google Scholar : PubMed/NCBI
13	Li Y, Ren H, Ren M, Cui F, Yang F, Chen Z, Cui L and Huang X: Morvan syndrome plus thyroid dysfunction: A case with chronic mercury exposure. Neurol India. 62:218–219. 2014. View Article : Google Scholar : PubMed/NCBI
14	Abgrall G, Demeret S, Rohaut B, Leu-Semenescu S and Arnulf I: Status dissociatus and disturbed dreaming in a patient with Morvan syndrome plus myasthenia gravis. Sleep Med. 16:894–896. 2015. View Article : Google Scholar : PubMed/NCBI
15	Benedetti L, Franciotta D, Zoccarato M, Beronio A, Godani M, Schirinzi E, Siciliano G, Ciarmiello A and Del Sette M: Post-therapy normalization of brain FDG-PET in Morvan's syndrome. J Neurol Sci. 353:175–176. 2015. View Article : Google Scholar : PubMed/NCBI
16	Ehler E and Meleková A: Neuromyotonia with polyneuropathy, prominent psychoorganic syndrome, insomnia, and suicidal behavior without antibodies: A case report. J Med Case Rep. 9:1012015. View Article : Google Scholar : PubMed/NCBI
17	Baas G Horta: Intravenous immunoglobulin therapy in Morvan syndrome secondary to recurrent thymic carcinoma. Medwave. 15:e63232015.(In Spanish). View Article : Google Scholar : PubMed/NCBI
18	Baiardi S, Provini F, Avoni P, Pasquinelli M and Liguori R: Immunotherapy of oneiric stupor in Morvan syndrome: Efficacy documented by actigraphy. Neurology. 84:2457–2459. 2015. View Article : Google Scholar : PubMed/NCBI
19	Laurencin C, André-Obadia N, Camdessanché JP, Mauguière F, Ong E, Vukusic S, Peter-Derex L, Meyronet D, Bouhour F, Vial C, et al: Peripheral small fiber dysfunction and neuropathic pain in patients with Morvan syndrome. Neurology. 85:2076–2078. 2015. View Article : Google Scholar : PubMed/NCBI
20	Lotan I, Djaldetti R, Hellman MA and Benninger F: Atypical case of Morvan's syndrome. J Clin Neurosci. 25:132–134. 2016. View Article : Google Scholar : PubMed/NCBI
21	Macaron G, El Rassy E and Koussa S: Morvan syndrome secondary to thymic carcinoma in a patient with systemic lupus erythematosus. Case Rep Neurol Med. 2016:91424862016.PubMed/NCBI
22	Mather H: A complicated case of metastatic thymoma. BMJ Support Palliat Care. 6:116–118. 2016. View Article : Google Scholar : PubMed/NCBI
23	Zhang L, Lu Q, Guan HZ, Mei JH, Ren HT, Liu MS, Peng B and Cui LY: A Chinese female Morvan patient with LGI1 and CASPR2 antibodies: A case report. BMC Neurol. 16:372016. View Article : Google Scholar : PubMed/NCBI
24	Maskery M, Chhetri SK, Dayanandan R, Gall C and Emsley HC: Morvan syndrome: A case report with patient narrative and video. Neurohospitalist. 6:32–35. 2016. View Article : Google Scholar : PubMed/NCBI
25	Detterbeck FC, Nicholson AG, Kondo K, Van Schil P and Moran C: The Masaoka-Koga stage classification for thymic malignancies: Clarification and definition of terms. J Thorac Oncol. 6(7 Suppl 3): S1710–S17168. 2011. View Article : Google Scholar : PubMed/NCBI
26	Travis WD, Brambilla E, Müller-Hermelink HK and Harris CC: World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart (3rd). IARC Press. (Lyon). 2004.
27	Ware JE Jr and Sherbourne CD: The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 30:473–483. 1992. View Article : Google Scholar : PubMed/NCBI
28	Eng TY, Fuller CD, Jagirdar J, Bains Y and Thomas CR Jr: Thymic carcinoma State of the art review. Int J Radiat Oncol Biol Phys. 59:654–664. 2004. View Article : Google Scholar : PubMed/NCBI
29	Kegel L, Aunin E, Meijer D and Bermingham JR: LGI proteins in the nervous system. ASN Neuro. 5:167–181. 2013. View Article : Google Scholar : PubMed/NCBI
30	Irani SR, Alexander S, Waters P, Kleopa KA, Pettingill P, Zuliani L, Peles E, Buckley C, Lang B and Vincent A: Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia. Brain. 133:2734–2748. 2010. View Article : Google Scholar : PubMed/NCBI
31	Arroyo EJ, Xu YT, Zhou L, Messing A, Peles E, Chiu SY and Scherer SS: Myelinating Schwann cells determine the internodal localization of Kv1.1, Kv1.2, Kvbeta2, and Caspr. J Neurocytol. 28:333–347. 1999. View Article : Google Scholar : PubMed/NCBI
32	Poliak S, Gollan L, Martinez R, Custer A, Einheber S, Salzer JL, Trimmer JS, Shrager P and Peles E: Caspr2, a new member of the neurexin superfamily, is localized at the juxtaparanodes of myelinated axons and associates with K+ channels. Neuron. 24:1037–1047. 1999. View Article : Google Scholar : PubMed/NCBI
33	Plantone D, Renna R and Koudriavtseva T: Neurological diseases associated with autoantibodies targeting the voltage-gated potassium channel complex: Immunobiology and clinical characteristics. Neuroimmunol Neuroinflamm. 3:69–78. 2016.
34	Bernard C, Frih H, Pasquet F, Kerever S, Jamilloux Y, Tronc F, Guibert B, Isaac S, Devouassoux M, Chalabreysse L, et al: Thymoma associated with autoimmune diseases: 85 cases and literature review. Autoimmun Rev. 15:82–92. 2016. View Article : Google Scholar : PubMed/NCBI
35	Cottrell DA, Blackmore KJ, Fawcett PRW, Birchall D, Vincent A, Barnard S and Walls TJ: Sub-acute presentation of Morvan's syndrome after thymectomy. J Neurol Neurosurg Psychiatry. 75:1504–510. 2004. View Article : Google Scholar : PubMed/NCBI
36	Lai M, Huijbers MG, Lancaster E, Graus F, Bataller L, Balice-Gordon R, Cowell JK and Dalmau J: Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: A case series. Lancet Neurol. 9:776–785. 2010. View Article : Google Scholar : PubMed/NCBI